Posts

Tyler Merkeley, CARB-X co-founder and program director for ASPR’s Biomedical Advanced Research and Development Authority, describes the drivers and next steps in creating a diverse portfolio Powered by CARB-X, one of the world’s largest public-private partnerships dedicated to accelerating development of innovative antibacterial drugs, diagnostics, and devices.

 

 

 

The National Institute of Allergies and Infectious Diseases (NIAID) awards close to $6,000,000,000 annually. Taking into account activities by DTRA, DARPA, US Army, BARDA, etc., this is a funding force no one in the field can afford to ignore.

In this webinar, we introduce you to Biodefense and Infectious Diseases sources of funding such as NIAID, DTRA, DARPA, US Army, and BARDA, and give examples of current open solicitations. We discuss the process for applying, major challenges, and how to maximize your chances for award.

 

View Slide Deck

Dr. Ronald Hann of the Defense Threat Reduction Agency (DTRA) presents the keynote address on Preparing for the Unthinkable.

 

View Slide Deck